C Cullinan Therapeutics, Inc.: insider trades · United States · SEC (Form 4) Discover the full management transaction log of Cullinan Therapeutics, Inc., a listed equity based in United States. Shares trade on US US, under the oversight of SEC (Form 4). Market capitalisation: €929.2m. The latest transaction was reported on 21 October 2025 (Acquisition). Among the most active insiders: Michaelson Jennifer. The full history is accessible without an account.
€894,665
13 ops.
Sell Volume
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Last declaration on 21 October 2025
All Executives27 Thresholds0 Prospectus0 Other0
Declarations 27 total
▲ 10% Owner · Executives · 14 Oct 2025
15,032 shares @ US$7.587 5.5% of flow Common stock, $0.0001 par value per share ("Common Stock") SEC:0000902664-25-004499:0
Ideal exit: 11 Jul 2026 (T+270) ▲ 10% Owner · Executives · 15 Oct 2025
51,500 shares @ US$7.9427 19.5% of flow Common Stock SEC:0000902664-25-004499:1
Ideal exit: 12 Jul 2026 (T+270) ▲ 10% Owner · Executives · 16 Oct 2025
150,000 shares @ US$8.855 63.0% of flow Common Stock SEC:0000902664-25-004499:2
Ideal exit: 13 Jul 2026 (T+270) ▲ 10% Owner · Executives · 17 Oct 2025
32,217 shares @ US$7.8395 12.0% of flow Common Stock SEC:0000902664-25-004499:3
Ideal exit: 14 Jul 2026 (T+270) ▼ President and CEO · Executives · 25 Feb 2025
12,529 shares @ US$8.53 51.6% of flow Common Stock SEC:0000950170-25-029199:0
▼ Chief Legal Officer · Executives · 25 Feb 2025
3,756 shares @ US$8.53 44.7% of flow Common Stock SEC:0000950170-25-029197:0
▼ Chief Medical Officer · Executives · 25 Feb 2025
4,895 shares @ US$8.53 44.2% of flow Common Stock SEC:0000950170-25-029201:0
▼ Chief Scientific Officer · Executives · 25 Feb 2025
3,756 shares @ US$8.53 4.0% of flow Common Stock SEC:0000950170-25-029200:0
◆ Chief Medical Officer · Executives · 19 Feb 2025
65,000 shares 0Common Stock SEC:0000950170-25-025028:0
◆ Chief Business Officer · Executives · 19 Feb 2025
37,500 shares 0Common Stock SEC:0000950170-25-025031:0
◆ Chief Legal Officer · Executives · 19 Feb 2025
50,000 shares 0Common Stock SEC:0000950170-25-025030:0
◆ President and CEO · Executives · 19 Feb 2025
180,000 shares 0Common Stock SEC:0000950170-25-025029:0
◆ Chief Financial Officer · Executives · 19 Feb 2025
60,000 shares 0Common Stock SEC:0000950170-25-025027:0
◆ Chief Scientific Officer · Executives · 19 Feb 2025
50,000 shares 0Common Stock SEC:0000950170-25-025032:0
▼ Chief Scientific Officer · Executives · 6 Jan 2025
4,000 shares @ US$12.51 6.4% of flow Common Stock SEC:0000950170-25-002946:0
▼ President and CEO · Executives · 24 Dec 2024
8,400 shares @ US$11.87 48.4% of flow Common Stock SEC:0000950170-24-140856:0
▼ Chief Legal Officer · Executives · 18 Dec 2024
3,482 shares @ US$11.41 55.3% of flow Common Stock SEC:0000950170-24-139123:0
▼ Chief Medical Officer · Executives · 18 Dec 2024
4,632 shares @ US$11.41 55.8% of flow Common Stock SEC:0000950170-24-139124:0
▼ Chief Scientific Officer · Executives · 18 Dec 2024
4,693 shares @ US$11.41 6.7% of flow Common Stock SEC:0000950170-24-139125:0
▼ Chief Scientific Officer · Executives · 12 Dec 2024
3,489 shares @ US$12.52 5.5% of flow Common Stock SEC:0000950170-24-136726:0
▼ Chief Scientific Officer · Executives · 5 Nov 2024
8,000 shares @ US$15.64 15.2% of flow Common Stock SEC:0000950170-24-123538:0
▼ Chief Scientific Officer · Executives · 5 Sept 2024
8,000 shares @ US$18.09 17.2% of flow Common Stock SEC:0000950170-24-104820:0
▼ Chief Scientific Officer · Executives · 5 Jul 2024
8,000 shares @ US$16.33 16.0% of flow Common Stock SEC:0000950170-24-082485:0
◆ Chief Scientific Officer · Executives · 1 Jul 2024
2,360 shares @ US$9.00 2.6% of flow Common Stock SEC:0000950170-24-080961:0
◇ Director · Executives · 10 Jun 2024
18,450 shares @ US$13.00 39.9% of flow Common Stock SEC:0000950170-24-072095:0
25 of 27 declarations
Load more (2 remaining)